GSK has won 22 government orders for its H1N1 swine flu vaccine in the past two months, taking total sales to 440m doses which media reports suggest will earn the company £2.2bn ($3.5bn).
Xceleron will provide services to GSK and its collaborators, such as academics and biotechs, under a novel deal that emphasises the big pharma’s attempts to change its drug development model.
UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.
GlaxoSmithKline (GSK) is to take a 16 per cent stake in Aspen in exchange for a manufacturing facility and eight medicines, building on the companies’ relationship and the big pharma’s profile in Africa.
An open house at GSK’s plant in Pennsylvania, US gave the world its first glimpse of the facility that the firm hopes will become the global hub of its vaccine packaging and filling business.
GlaxoSmithKline (GSK) is stopping making corporate political contributions as part of its transparency drive but employees can still donate through the Political Action Committee (PAC).
UK drug major GlaxoSmithKline is examining operations at its active
pharmaceutical ingredient (API) manufacturing plant in Montrose,
Scotland, with an eye to potential job cuts.
The pharmaceutical industry in the UK faces tougher legislation on
the disclosure of adverse events in clinical trials following the
MHRA's thwarted attempt to prosecute GlaxoSmithKline for allegedly
withholding information about...
A UK chemicals plant has become the latest casualty of
GlaxoSmithKline's (GSK's) pledge to make the business leaner with
the help of outsourcing and offshoring.
GlaxoSmithKline (GSK) has been swift in implementing its plant
cuts, already announcing the first sites to be axed mere hours
after revealing its restructuring plans.
GlaxoSmithKline (GSK) has emerged as the latest pharma firm to
announce closures and job cuts along with its third quarter
results, yet another casualty of generic competition and product
safety scares.
GlaxoSmithKline (GSK) thinks that drugs based on boron, rather than
carbon, could side-step the issue of resistance in anti-bacterial
and anti-viral therapy - and is willing to bet billions on it.
GlaxoSmithKline (GSK) outlined more details on the mechanism of its
anticancer drug ofatumumab - an antibody that was the subject of
the biggest ever pharma licensing deal.
The significance of the aborted deal between GlaxoSmithKline and
Cobra has been exaggerated due to GSK's high profile and is not the
end of the world, the British contract manufacturer said.
Three doctors from a Russian hospital hired to run clinical trials
for GlaxoSmithKline (GSK) have now been charged by local
prosecutors over alleged illegal practices during the study on
children.
A drug discovery collaboration between Ranbaxy and GlaxoSmithKline
(GSK) is bearing fruit with the companies stepping up their
respiratory inflammation research.
GlaxoSmithKline (GSK) has announced plans to outsource all its data
management and medical trial and regulatory reporting functions to
India in a deal said to be worth over £10m (€14.7m).
GlaxoSmithKline (GSK) has today opened a new medicinal chemistry
laboratory in Singapore and plans to double the number of
researchers hired at the site to 60.
GlaxoSmithKline (GSK) has denied allegations that some of its
vaccines have been tested illegally and against good clinical
practice (GCP) in children in Russia.
GlaxoSmithKline (GSK) has stopped development of several drugs,
leaving some industry experts to wonder if the company's cap on
research spending is stifling drug development.
GlaxoSmithKline (GSK) has acquired licensing rights outside the US
to the over the counter (OTC) weight-loss medication orlistat,
previously marketed by Roche.
GlaxoSmithKline (GSK) has decided to consolidate all its human
resources business process outsourcing (BPO) services under the one
umbrella in a contract valued at $171m (€131m).
Major pharmaceutical player GlaxoSmithKline (GSK) has begun
construction of a €23m facility in County Waterford, Ireland. The
new facility is already under construction at the company's
consumer healthcare manufacturing site...
Drug giant GlaxoSmithKline (GSK) has been awarded a contract with
the US government to supply 800,000 doses of flu vaccine to the US,
where a bird flu pandemic still remains a threat.
Italian drug delivery technology developer Eurand has signed a $42m
(€33m) licensing deal with GlaxoSmithKline (GSK) to make a new
formulation of one of the British pharma giant's drugs.
Responding to Roche's licensing agreements for Tamiflu (oseltamivir
phosphate) around the world, GlaxoSmithKline (GSK) has granted
China's Simcere Pharmaceutical Group the right to make generic
copies of its influenza drug...
GlaxoSmithKline (GSK) has formed a partnership with ChemoCentryx
worth $1.5bn (€1.2bn) which will provide the company with access to
selected targets from one of the broadest pipelines of
chemokine-based therapeutics in the biotech...
GlaxoSmithKline (GSK), a major player in vaccine manufacturing, is
set to inaugurate a €100m vaccine production plant on Friday in a
Hungarian city 30Km northeast of Budapest.
GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...
In the company's largest investment of its kind in Asia,
GlaxoSmithKline (GSK) has decided to build a new vaccine
manufacturing plant in Singapore, as several products in its
pipeline approach commercialisation.
The High Court in the UK has granted an injunction to protect
GlaxoSmithKline (GSK) shareholders against the recent threat posed
by animal extremists, who contacted investors by mail warning them
to sell their shares in the company.
Animal rights activists have continued their campaign of
intimidation after it was revealed the GlaxoSmithkline (GSK)
shareholders were sent letters demanding they sell any shares held
within the company.
GlaxoSmithKline (GSK) has begun distributing Trizivir tagged with
radio frequency identification (RFID) technology as it intensifies
efforts to combat counterfeiting.
Cryopak Industries has struck a deal to supply GlaxoSmithKline
(GSK) with insulated containers and internal thermal components for
shipping of its temperature sensitive vaccines in Canada.
GlaxoSmithKline is planning to use a series of packaging and
on-tablet technologies to prevent parallel trade in its HIV drugs
Combivir (zidovudine and lamivudine) and Epivir (lamivudine),
writes Phil Taylor.
GlaxoSmithKline (GSK) has created a Centre of Excellence for
External Drug Discovery (CEEDD) that aims to provide GSK with
alternative scientific and drug discovery approaches. The CEEDD
also aims to exploit the full potential of...
GlaxoSmithKline has announced plans to acquire the Corixa
Corporation, which represents an important strategic deal for GSK's
vaccines division, GSK Bio. The division is the only major vaccine
maker with active R&D programs...
There is speculation that the problems at GlaxoSmithKline's
manufacturing facility in Puerto Rico may prove to be more costly
for the company than originally thought.
Theravance has announced that GlaxoSmithKline (GSK) has exercised
its option to license Theravance's inhaled bifunctional, muscarinic
antagonist/beta2 agonist (MABA) program under the terms of their
2004 agreement. The compounds...
The European approval of a new high-potency vaccine for hepatitis B
virus (HBV) marks the debut on the marketplace of a new adjuvant
ingredient that can significantly improve the effectiveness of
immunisations, reports Phil Taylor.
GlaxoSmithKline (GSK) is facing a number of US lawsuits, which
claims the company had covered up negative data that indicated its
antidepressant Paxil might increase suicidal tendencies in young
people.
GlaxoSmithKline (GSK) became the first major drug maker to disclose
details of its clinical drug trials effectively settling a lawsuit
filed by the New York state attorney general, Eliot Spitzer, who
accused them of concealing information...
GlaxoSmithKline today announced details of its seventh Centre of
Excellence for Drug Discovery (CEDD), extending the company's new
model for pharmaceutical R&D into the biopharmaceutical sphere.
GSK has opened a new high-throughput chemistry facility at its
Harlow research centre in Essex, UK, that it hopes will allow it to
cut down its drug development time by around two years. This and
other automation projects at the company...
GlaxoSmithKline has secured rights to a technology, developed in
partnership with US company Advaxis, could improve the
effectiveness of vaccine-based treatments for cancer.
Pharmaceutical major GlaxoSmithKline has set aside £1 million
(€1.4m) to soften the blow of selling its bulk active ingredient
manufacturing facility in Montrose.